Engineering Tumor-Specific Gene Nanomedicine to Recruit and Activate T Cells for Enhanced Immunotherapy

Investigators devised tumor-specific gene nanomedicines to mobilize tumor cells to secrete CXCL9 and anti-PD-L1 scFv for enhanced immunotherapy.